# A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)

Study · id `cardio:ct-nct05961787` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05961787](<https://clinicaltrials.gov/study/NCT05961787>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05961787

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 134 participants.

## Technical summary

Registry record NCT05961787. Randomized; no masking; primary purpose treatment. Start 2022-12-30 (actual); primary completion 2025-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 134 participants (planned count; ClinicalTrials.gov record NCT05961787, source copy `cardio:ctgov-nct05961787-2023-07-27`, retrieved 2026-10-26)
- Started: 2022-12-30 (actual) (ClinicalTrials.gov record NCT05961787, source copy `cardio:ctgov-nct05961787-2023-07-27`, retrieved 2026-10-26)
- Primary completion: 2025-01 (anticipated) (ClinicalTrials.gov record NCT05961787, source copy `cardio:ctgov-nct05961787-2023-07-27`, retrieved 2026-10-26)
- Completion: 2026-01 (anticipated) (ClinicalTrials.gov record NCT05961787, source copy `cardio:ctgov-nct05961787-2023-07-27`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05961787, source copy `cardio:ctgov-nct05961787-2023-07-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05961787-2023-07-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)
- Acronym: LARGE-ONE
- Condition: Coronary Artery Disease
- Intervention (Device): SeQuent® Please drug coating balloon(DCB)，Firehawk family drug eluting stent(DES)
- Lead sponsor: Shanghai MicroPort Medical (Group) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. (`cardio:org-shanghai-microport-medical-group-co-ltd`)

## Provenance

Content hash: 8a27ea8a7d5faf45c75d5b869b3dfae9b1484ed37c72f392c384a424ea00ace5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
